Dolby Laboratories (DLB) Cash & Equivalents Growth (1y) (2016 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Relx |
81.40 Bn |
81.16 Bn |
- |
14.09% |
| 2 |
Rentokil Initial |
79.56 Bn |
78.10 Bn |
- |
17.08% |
| 3 |
Cintas |
69.26 Bn |
69.08 Bn |
1.45 Bn |
-24.74% |
| 4 |
Copart |
33.09 Bn |
28.01 Bn |
971.24 Mn |
52.80% |
| 5 |
UL Solutions |
20.56 Bn |
20.32 Bn |
381.00 Mn |
-3.37% |
| 6 |
Global Payments |
19.88 Bn |
14.69 Bn |
1.70 Bn |
115.96% |
| 7 |
Rb Global |
19.08 Bn |
18.89 Bn |
869.50 Mn |
-66.75% |
| 8 |
Aramark |
13.57 Bn |
13.16 Bn |
426.35 Mn |
-48.32% |
| 9 |
Amentum Holdings |
5.65 Bn |
5.74 Bn |
345.00 Mn |
- |
| 10 |
Dolby Laboratories |
5.15 Bn |
4.56 Bn |
350.90 Mn |
-5.15% |
| Date | Value |
|---|
| Mar 27, 2026 |
-5.15% |
| Dec 26, 2025 |
23.62% |
| Sep 26, 2025 |
45.61% |
| Jun 27, 2025 |
-5.81% |
| Mar 28, 2025 |
-11.70% |
| Dec 27, 2024 |
-20.71% |
| Sep 27, 2024 |
-35.33% |
| Jun 28, 2024 |
-3.06% |
| Mar 29, 2024 |
3.06% |
| Dec 29, 2023 |
4.90% |
| Sep 29, 2023 |
20.20% |
| Jun 30, 2023 |
-10.92% |
| Mar 31, 2023 |
-23.54% |
| Dec 30, 2022 |
-40.74% |
| Sep 30, 2022 |
-49.39% |
| Jul 1, 2022 |
-29.58% |
| Apr 1, 2022 |
-18.48% |
| Dec 31, 2021 |
-4.81% |
| Sep 24, 2021 |
14.32% |
| Jun 25, 2021 |
42.63% |
| Mar 26, 2021 |
52.37% |
| Dec 25, 2020 |
49.71% |
| Sep 25, 2020 |
34.45% |
| Jun 26, 2020 |
19.33% |
| Mar 27, 2020 |
-0.23% |
| Dec 27, 2019 |
-6.24% |
| Sep 27, 2019 |
-13.16% |
| Jun 28, 2019 |
-13.63% |
| Mar 29, 2019 |
2.99% |
| Dec 28, 2018 |
32.60% |
| Sep 28, 2018 |
44.72% |
| Jun 29, 2018 |
39.99% |
| Mar 30, 2018 |
19.05% |
| Dec 29, 2017 |
16.29% |
| Sep 29, 2017 |
22.05% |
| Jun 30, 2017 |
-1.23% |
| Mar 31, 2017 |
13.70% |
| Dec 30, 2016 |
9.79% |
| Sep 30, 2016 |
-2.29% |
| Jul 1, 2016 |
27.42% |
